Peter L. Greenberg

Also affiliated with Stanford University

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes”.

Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes

Cell(2012)10.1016/j.cell.2012.02.009

N/A

1.1DataRank · unranked

1301 citations

George I. Mias, Jennifer Li-Pook-Than, Lihua Jiang, Rong Chen, Elana Miriami +42 more

Finding consistency in classifications of myeloid neoplasms: a perspective on behalf of the International Workshop for Myelodysplastic Syndromes

Leukemia(2022)10.1038/s41375-022-01724-9

N/A

0.926DataRank · unranked

28 citations

Jan Philipp Bewersdorf, Rena Buckstein, Mikkael A. Sekeres, David P. Steensma, Uwe Platzbecker +44 more

Relationship of differential gene expression profiles in CD34+ myelodysplastic syndrome marrow cells to disease subtype and progression

Blood(2009)10.1182/blood-2009-08-236422

N/A

0.628DataRank · unranked

65 citations

Douglas T. Ross, Robert Tibshirani, Atul Janardhan Butte, Peter L. Greenberg, Kunju Sridhar

An agenda to advance research in myelodysplastic syndromes: a TOP 10 priority list from the first international workshop in MDS

Blood Advances(2022)10.1182/bloodadvances.2022008747

N/A

0.525DataRank · unranked

11 citations

Omar Abdel-Wahab, Andrew H. Wei, Michael R. Savona, Mina L. Xu, Zhuoer Xie +45 more

Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms

Leukemia(2021)10.1038/s41375-021-01328-9

N/A

0DataRank · unranked

183 citations

Martin Wermke, Virginia M. Klimek, Peter L. Greenberg, Patricia Font, Rami S. Komrokji +35 more

Profiling myelodysplastic syndromes by mass cytometry demonstrates abnormal progenitor cell phenotype and differentiation

Cytometry Part B Clinical Cytometry(2020)10.1002/cyto.b.21860

N/A

0DataRank · unranked

35 citations

Rachel Finck, Nikolay Samusik, Kunju Sridhar, Wendy J. Fantl, Peter L. Greenberg +2 more

Classification, risk stratification and response assessment in myelodysplastic syndromes/neoplasms (MDS): A state-of-the-art report on behalf of the International Consortium for MDS (icMDS)

Blood Reviews(2023)10.1016/j.blre.2023.101128

N/A

0DataRank · unranked

31 citations

Jan Philipp Bewersdorf, Zhuoer Xie, Matteo Giovanni Della Porta, Rami S. Komrokji, Mina L. Xu +43 more

Shared and Distinct Mechanisms of UBA1 Inactivation Across Different Diseases

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.10.561769

N/A

0DataRank · unranked

7 citations

Samuel J. Magaziner, Maya English, Bakar A. Hassan, Xiang Chen, Nicholas Balanda +14 more

Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes

Blood(2024)10.1182/blood.2023023723

N/A

0DataRank · unranked

52 citations

Elsa Bernard, Maria Creignou, Dylan Domenico, Andrea Farina, Juan Arango Ossa +55 more

Shared and distinct mechanisms of UBA1 inactivation across different diseases

The EMBO Journal(2024)10.1038/s44318-024-00046-z

N/A

0DataRank · unranked

41 citations

Samuel J. Magaziner, Maya English, Bakar A. Hassan, Xiang Chen, Nicholas Balanda +14 more

Contemporary Approach to the Diagnosis and Classification of Myelodysplastic Neoplasms/Syndromes—Recommendations From the International Consortium for Myelodysplastic Neoplasms/Syndromes (MDS [icMDS])

Modern Pathology(2024)10.1016/j.modpat.2024.100615

N/A

0DataRank · unranked

12 citations

Savanah D. Gisriel, Amer M. Zeidan, John M. Bennett, Rafael Bejar, Jan Philipp Bewersdorf +48 more